Your browser doesn't support javascript.
loading
Perspectives of Implementation of Closed-Loop Deep Brain Stimulation: From Neurological to Psychiatric Disorders.
Groppa, Sergiu; Gonzalez-Escamilla, Gabriel; Tinkhauser, Gerd; Baqapuri, Halim Ibrahim; Sajonz, Bastian; Wiest, Christoph; Pereira, Joana; Herz, Damian M; Dold, Matthias R; Bange, Manuel; Ciolac, Dumitru; Almeida, Viviane; Neuber, John; Mirzac, Daniela; Martín-Rodríguez, Juan Francisco; Dresel, Christian; Muthuraman, Muthuraman; Adarmes Gomez, Astrid D; Navas, Marta; Temiz, Gizem; Gunduz, Aysegul; Rotaru, Lilia; Winter, Yaroslav; Schuurman, Rick; Contarino, Maria F; Glaser, Martin; Tangermann, Michael; Leentjens, Albert F G; Mir, Pablo; Torres Diaz, Cristina V; Karachi, Carine; Linden, David E J; Tan, Huiling; Coenen, Volker A.
  • Groppa S; Movement Disorders and Neurostimulation, Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Gonzalez-Escamilla G; Movement Disorders and Neurostimulation, Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Tinkhauser G; Department of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland.
  • Baqapuri HI; School for Mental Health and Neuroscience, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Sajonz B; Department of Stereotactic and Functional Neurosurgery, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Wiest C; MRC Brain Network Dynamics Unit, Department of Clinical Neurosciences, University of Oxford, Oxford, UK.
  • Pereira J; Department of Stereotactic and Functional Neurosurgery, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
  • Herz DM; Movement Disorders and Neurostimulation, Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Dold MR; Department of Artificial Intelligence, Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
  • Bange M; Movement Disorders and Neurostimulation, Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Ciolac D; Movement Disorders and Neurostimulation, Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Almeida V; Movement Disorders and Neurostimulation, Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Neuber J; Movement Disorders and Neurostimulation, Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Mirzac D; Movement Disorders and Neurostimulation, Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Martín-Rodríguez JF; Servicio de Neurología y Neurofisiología Clínica, Unidad de Trastornos del Movimiento, Instituto de Biomedicina de Sevilla, (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
  • Dresel C; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
  • Muthuraman M; Departamento de Psicología Experimental, Facultad de Psicología, Universidad de Sevilla, Seville, Spain.
  • Adarmes Gomez AD; Movement Disorders and Neurostimulation, Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Navas M; Movement Disorders and Neurostimulation, Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine-Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
  • Temiz G; Servicio de Neurología y Neurofisiología Clínica, Unidad de Trastornos del Movimiento, Instituto de Biomedicina de Sevilla, (IBiS), Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
  • Gunduz A; Centro de Investigación Biomédica en Red Sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain.
  • Rotaru L; Departamento de Medicina, Facultad de Medicina, Universidad de Sevilla, Seville, Spain.
  • Winter Y; Department of Functional Neurosurgery, Hospital Ruber International, Madrid, Spain.
  • Schuurman R; Neurosurgery Department, Hôpital de la Salpêtrière, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Contarino MF; Department of Biomedical Engineering, University of Florida, Gainesville, Florida, USA.
  • Glaser M; Department of Neurology, Norman Fixel Institute for Neurological Diseases, Gainesville, Florida, USA.
  • Tangermann M; Department of Neurosurgery, Norman Fixel Institute for Neurological Diseases, Gainesville, Florida, USA.
  • Leentjens AFG; Diomid Gherman Institute of Neurology and Neurosurgery Chisinau, Chișinau, Moldova.
  • Mir P; Department of Neurology, Mainz Comprehensive Epilepsy and Sleep Medicine Center, Johannes Gutenberg University Mainz, Mainz, Germany.
  • Torres Diaz CV; Department of Neurology, Philipps University, Marburg, Germany.
  • Karachi C; Department of Neurosurgery, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, The Netherlands.
  • Linden DEJ; Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands.
  • Tan H; Department of Neurology, Haga Teaching Hospital, The Hague, The Netherlands.
  • Coenen VA; Department of Neurosurgery, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany.
Stereotact Funct Neurosurg ; 102(1): 40-54, 2024.
Article en En | MEDLINE | ID: mdl-38086346
ABSTRACT

BACKGROUND:

Deep brain stimulation (DBS) is a highly efficient, evidence-based therapy to alleviate symptoms and improve quality of life in movement disorders such as Parkinson's disease, essential tremor, and dystonia, which is also being applied in several psychiatric disorders, such as obsessive-compulsive disorder and depression, when they are otherwise resistant to therapy.

SUMMARY:

At present, DBS is clinically applied in the so-called open-loop approach, with fixed stimulation parameters, irrespective of the patients' clinical state(s). This approach ignores the brain states or feedback from the central nervous system or peripheral recordings, thus potentially limiting its efficacy and inducing side effects by stimulation of the targeted networks below or above the therapeutic level. KEY MESSAGES The currently emerging closed-loop (CL) approaches are designed to adapt stimulation parameters to the electrophysiological surrogates of disease symptoms and states. CL-DBS paves the way for adaptive personalized DBS protocols. This review elaborates on the perspectives of the CL technology and discusses its opportunities as well as its potential pitfalls for both clinical and research use in neuropsychiatric disorders.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Estimulación Encefálica Profunda / Trastornos Mentales Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Enfermedad de Parkinson / Estimulación Encefálica Profunda / Trastornos Mentales Límite: Humans Idioma: En Año: 2024 Tipo del documento: Article